Matches in Wikidata for { <http://www.wikidata.org/entity/Q57751326> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q57751326 description "article scientifique (publié 2007)" @default.
- Q57751326 description "artikull shkencor i botuar më 01 janar 2007" @default.
- Q57751326 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q57751326 description "im Jahr 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57751326 description "scientific article published on 01 January 2007" @default.
- Q57751326 description "wetenschappelijk artikel" @default.
- Q57751326 description "наукова стаття, опублікована у 2006" @default.
- Q57751326 name "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 name "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 name "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 type Item @default.
- Q57751326 label "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 label "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 label "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 prefLabel "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 prefLabel "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 prefLabel "Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study" @default.
- Q57751326 P1433 Q57751326-9DC97BFF-C0AD-4C12-8BF6-893EA7291331 @default.
- Q57751326 P1476 Q57751326-5E9B187C-2F6B-4E6E-888D-EC95E56759BC @default.
- Q57751326 P2093 Q57751326-1F557344-A7A4-4503-87DC-DD632EC9379E @default.
- Q57751326 P2093 Q57751326-C194F915-4A8C-4A8A-BCAC-CBDB913D2478 @default.
- Q57751326 P2093 Q57751326-D1AF665C-B3E6-450F-AE8B-2517151A6792 @default.
- Q57751326 P2860 Q57751326-30005670-B655-4DBD-90D9-B27F8598C281 @default.
- Q57751326 P304 Q57751326-1877C440-EF2F-4C61-8A29-89BD5FBBD43D @default.
- Q57751326 P31 Q57751326-AB27112A-8DB5-4465-93FC-B198A069C732 @default.
- Q57751326 P356 Q57751326-93AC9644-C08B-46D9-8515-3B003480A952 @default.
- Q57751326 P433 Q57751326-51DB0897-48DC-4AAB-B906-C8D7DCF349C3 @default.
- Q57751326 P478 Q57751326-6BF04EC0-8253-4C20-B27B-4A90A07C018F @default.
- Q57751326 P50 Q57751326-62894698-9310-4576-B5B3-AA86F0943688 @default.
- Q57751326 P50 Q57751326-676A9F84-A2DD-42CC-8D54-7C4933228D6E @default.
- Q57751326 P50 Q57751326-BF0B2643-F79A-416F-9959-C44CC532C9FB @default.
- Q57751326 P577 Q57751326-C83DBB77-4F99-4A9F-9B4B-AE5032A80E52 @default.
- Q57751326 P698 Q57751326-CB6FEFDB-26B2-40FA-B2AD-A7C85CE65491 @default.
- Q57751326 P921 Q57751326-48E5B0C5-E8F5-482B-94A4-AA4F478CDDE8 @default.
- Q57751326 P921 Q57751326-AA053BE2-56E7-4877-BD7B-EAF5FD20A6E6 @default.
- Q57751326 P921 Q57751326-F5FC8FDB-CAEE-4FA4-94A6-6A8D424A53AA @default.
- Q57751326 P921 Q57751326-F7545D94-E0C2-4CA3-8368-B3D10BCF96C8 @default.
- Q57751326 P356 ART.22331 @default.
- Q57751326 P698 17195186 @default.
- Q57751326 P1433 Q23929027 @default.
- Q57751326 P1476 "Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study" @default.
- Q57751326 P2093 "Alan J Silman" @default.
- Q57751326 P2093 "British Society for Rheumatology Biologics Register" @default.
- Q57751326 P2093 "Kath D Watson" @default.
- Q57751326 P2860 Q52221782 @default.
- Q57751326 P304 "13-20" @default.
- Q57751326 P31 Q13442814 @default.
- Q57751326 P356 "10.1002/ART.22331" @default.
- Q57751326 P433 "1" @default.
- Q57751326 P478 "56" @default.
- Q57751326 P50 Q43081953 @default.
- Q57751326 P50 Q54100237 @default.
- Q57751326 P50 Q56956095 @default.
- Q57751326 P577 "2007-01-01T00:00:00Z" @default.
- Q57751326 P698 "17195186" @default.
- Q57751326 P921 Q101929 @default.
- Q57751326 P921 Q181600 @default.
- Q57751326 P921 Q187255 @default.
- Q57751326 P921 Q327657 @default.